首页> Frontiers in pharmacology> Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries.

Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lucia,Gozzo

第一单位： Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, University Hospital of Catania, Catania, Italy.;Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.

作者： Lucia,Gozzo ^[1] ; Giovanni Luca,Romano ^[2] ; Francesca,Romano ^[2] ; Serena,Brancati ^[3] ; Laura,Longo ^[3] ; Daniela Cristina,Vitale ^[3] ; Filippo,Drago ^[4]

作者单位： Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, University Hospital of Catania, Catania, Italy.;Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. ^[1] Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. ^[2] Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, University Hospital of Catania, Catania, Italy. ^[3] Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, University Hospital of Catania, Catania, Italy.;Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.;Centre for Research and Consultancy in HTA and Drug Regulatory Affairs (CERD) University of Catania, Catania, Italy. ^[4]

关键词 access added therapeutic value advanced medicinal products health technology assessment regulatory issue

DOI 10.3389/fphar.2021.755052

PMID 34690785

发布时间 2021-10-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交